These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23039767)

  • 21. Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?
    Borger E; Aitken L; Du H; Zhang W; Gunn-Moore FJ; Yan SS
    Curr Alzheimer Res; 2013 Jan; 10(1):21-9. PubMed ID: 22742981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol.
    Lim YA; Grimm A; Giese M; Mensah-Nyagan AG; Villafranca JE; Ittner LM; Eckert A; Götz J
    PLoS One; 2011; 6(12):e28887. PubMed ID: 22174920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimeŕs drugs dealing with cholinergic, amyloid and mitochondrial systems.
    Nepovimova E; Svobodova L; Dolezal R; Hepnarova V; Junova L; Jun D; Korabecny J; Kucera T; Gazova Z; Motykova K; Kubackova J; Bednarikova Z; Janockova J; Jesus C; Cortes L; Pina J; Rostohar D; Serpa C; Soukup O; Aitken L; Hughes RE; Musilek K; Muckova L; Jost P; Chvojkova M; Vales K; Valis M; Chrienova Z; Chalupova K; Kuca K
    Bioorg Chem; 2021 Feb; 107():104596. PubMed ID: 33421953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial β-amyloid in Alzheimer's disease.
    Borger E; Aitken L; Muirhead KE; Allen ZE; Ainge JA; Conway SJ; Gunn-Moore FJ
    Biochem Soc Trans; 2011 Aug; 39(4):868-73. PubMed ID: 21787315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice.
    Xiao X; Chen Q; Zhu X; Wang Y
    Neurobiol Aging; 2019 Sep; 81():77-87. PubMed ID: 31252207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction.
    Yan Y; Liu Y; Sorci M; Belfort G; Lustbader JW; Yan SS; Wang C
    Biochemistry; 2007 Feb; 46(7):1724-31. PubMed ID: 17253767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
    Marondedze EF; Govender KK; Govender PP
    J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
    He XY; Dobkin C; Brown WT; Yang SY
    J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
    El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
    Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer's Disease Treatment.
    Schmidt M; Benek O; Vinklarova L; Hrabinova M; Zemanova L; Chribek M; Kralova V; Hroch L; Dolezal R; Lycka A; Prchal L; Jun D; Aitken L; Gunn-Moore F; Kuca K; Musilek K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X; Yan SD
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase.
    He XY; Dobkin C; Brown WT; Yang SY
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).
    Yan SD; Stern DM
    Int J Exp Pathol; 2005 Jun; 86(3):161-71. PubMed ID: 15910550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
    Muirhead KE; Borger E; Aitken L; Conway SJ; Gunn-Moore FJ
    Biochem J; 2010 Feb; 426(3):255-70. PubMed ID: 20175748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment.
    Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors.
    Safarizadeh H; Garkani-Nejad Z
    J Mol Graph Model; 2019 Mar; 87():129-143. PubMed ID: 30537643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.